Prokidney (PROK) Total Current Liabilities (2021 - 2026)
Prokidney's (PROK) quarterly Total Current Liabilities came in at $22.7 million in Q2 2026, down 19.64% year-over-year from $28.3 million in Q2 2025, and down 12.42% quarter-over-quarter from $25.9 million in Q1 2026.
Analysis
Prokidney (PROK) Total Current Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Total Current Liabilities for 6 consecutive years, with $22.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 19.64% year-over-year to $22.7 million in Q2 2026; TTM through Jun 2026 was $22.7 million, a 19.64% decrease from a year earlier, with the FY2025 full-year figure at $30.7 million, down 15.12% from the prior year.
- Total Current Liabilities was $22.7 million for Q2 2026 at Prokidney, down from $25.9 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $36.2 million in Q4 2024 and troughed at $5.4 million in Q1 2022.
- A 5-year average of $21.5 million and a median of $23.6 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 17747.95% in 2022 and retreated 20.96% in 2026, its largest moves.
- Over 5 years, Total Current Liabilities stood at $10.9 million in 2022, then surged by 130.28% to $25.0 million in 2023, then surged by 44.65% to $36.2 million in 2024, then slipped by 15.12% to $30.7 million in 2025, then slipped by 26.13% to $22.7 million in 2026.
- The last three Total Current Liabilities figures came in at $22.7 million (Q2 2026), $25.9 million (Q1 2026), and $30.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 127.40 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 132.90 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 106.85 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 403.60 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 83.35 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 80.88 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 29.35 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 502.91 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 52.53 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 22.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.71 Mn |
| Mar 31, 2026 | 25.93 Mn |
| Dec 31, 2025 | 30.74 Mn |
| Sep 30, 2025 | 29.06 Mn |
| Jun 30, 2025 | 28.26 Mn |
| Mar 31, 2025 | 32.81 Mn |
| Dec 31, 2024 | 36.22 Mn |
| Sep 30, 2024 | 25.18 Mn |
| Jun 30, 2024 | 20.59 Mn |
| Mar 31, 2024 | 19.30 Mn |
| Dec 31, 2023 | 25.04 Mn |
| Sep 30, 2023 | 20.99 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 9.84 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | 5.41 Mn |
| Dec 31, 2021 | 12.31 Mn |
| Sep 30, 2021 | 55,138.00 |